Edition:
India

AB Science Announces Masitinib Phase 3 Study In Alzheimer's Disease Completed Patient Recruitment


Monday, 22 Oct 2018 

Oct 22 (Reuters) - AB SCIENCE SA ::REG-AB SCIENCE ANNOUNCES THAT THE MASITINIB PHASE 3 STUDY IN ALZHEIMER'S DISEASE HAS COMPLETED PATIENT RECRUITMENT.FINAL RESULTS WILL BE AVAILABLE IN 2019.STUDY RECRUITMENT WAS COMPLETED WITH 721 ENROLLED PATIENTS.NEXT STEP FOR THIS STUDY IS A PRE-PLANNED INTERIM ANALYSIS, WHICH IS EXPECTED IN COMING MONTHS. 

Company Quote

4.685
0.105 +2.29%
23 Apr 2019